PATHWARD director granted 1,650 shares of stock
PATHWARD FINANCIAL, INC. director Christopher Perretta reported an equity award of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PATHWARD FINANCIAL, INC. director Christopher Perretta reported an equity award of company stock. He acquired 1,650 shares of common stock on February 24, 2026 at a stated price of $0.00 per share, reflecting a grant rather than an open-market purchase. Following this award, his directly owned position increased to 8,350 common shares. The filing notes that the award was granted pursuant to the company’s 2023 Omnibus Incentive Plan, which is used to provide stock-based compensation to eligible participants.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,650 | $0.00 | $0.00 |
Footnotes (1)
- F1. Award pursuant to the Company's 2023 Omnibus Incentive Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PATHWARD FINANCIAL (CASH) report for Christopher Perretta?
Was the PATHWARD FINANCIAL (CASH) insider transaction a market purchase or a stock grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.